SOLICITATION NOTICE
A -- NIH AIDS Research and Reference Reagent Program
- Notice Date
- 11/23/2004
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Program 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- NIH-NIAID-DAIDS-05-18
- Response Due
- 3/9/2005
- Archive Date
- 3/24/2005
- Description
- The Division of Acquired Immunodeficiency Syndrome (DAIDS), of the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH), intends to compete a requirement currently being performed by McKesson BioServices Corporation under Contract No. N01-AI-85332. This solicitation is being issued under full and open competitive procedures. DAIDS (www.niaid.nih.gov/daids) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Today, with the ever-changing demographics of the epidemic, DAIDS is expanding its focus to a more global research agenda with an emphasis on an integrated prevention and therapeutics agenda in developing nations. Specifically, the mission of DAIDS is to help ensure an end to the HIV/AIDS epidemic by increasing basic knowledge of the pathogenesis and transmission of the human immunodeficiency virus, or HIV, supporting the development of therapies for HIV infection and its complications, and supporting the development of vaccines and other prevention strategies. Through the contemplated contract, DAIDS supports the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program (ARP) in achieving its goal of providing critical research reagents and resources to the scientific community. An important rate-limiting step in basic research is the identification and distribution of state-of-the-art reagents and technology. Since its establishment in 1988, the ARP has evolved from a small bank of research materials to a unique and versatile worldwide resource of critical reagents not otherwise readily available to the HIV/AIDS research community. In 2002, the ARP contract was amended to provide reagents for biodefense research and other infectious diseases including transmissible spongiform encephalopathies (TSE). In addition to research reagents for HIV/AIDS, the ARP has provided reagents for hepatitis C virus, anthrax and Severe Acute Respiratory Syndrome (SARS) coronavirus research. The ARP acquires state-of-the-art reagents; produces these reagents, standardized panels, and protocols; and then provides these reagents at minimal cost to qualified investigators throughout the world. Additionally, the ARP collects information about AIDS-related reagents and standards and disseminates this information through print, electronic media, and enhances technology transfer by developing standard reagents and kits, and sponsoring workshops on their use. ARP facilitates commercial development of reagents through proactive communications with biotechnology and pharmaceutical companies. In 2002, ARP promoted commercial development of MHC class I/peptide tetramers by developing a market for these reagents. Availability of quality controlled, custom made tetramers through the ARP resulted in their increased use and demand, which is now met by the commercial sector. ARP participates as an AIDS Collaborating Center of the joint United Nations Program in HIV/AIDS (UNAIDS), and the United Kingdom?s National Institute for Biological Standards and Control (NIBSC) Centralized Facility for AIDS Reagents. It is anticipated that a single cost reimbursement, completion type contract will be awarded for a 7-year period of performance beginning on or about September 26, 2005. This RFP will be available electronically on/about December 10, 2004, and may be accessed through the NIAID Contract Management Program (CMP) Home Page at http://www.niaid.nih.gov/contract and on FedBizOpps. Any responsible offeror may submit a proposal that will be considered by the Government. This notice does not commit the Government to award of a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. See Government-Wide Numbered Note 26.
- Record
- SN00712187-W 20041125/041123211737 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |